The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia
Hiten Naik et al. Online issue publication May 13, 2024
Griffith University researchers to trial naltrexone on long COVID patients
By Janelle Miles and Emma Pollard
Posted Mon 6 May 2024
https://www.abc.net.au/news/2024-05-07/qld-griffith-university-trial-naltrexone-long-covid/103800050
Jayden Donald went from a fit and healthy teenager who rode his horses almost every day, to being so sick he could hardly sit up after his second bout of COVID-19.
Exciting breakthrough offers hope for Long COVID patients
Published May 7, 2024
Author Emma O'Connor - Griffith University
https://news.griffith.edu.au/2024/05/07/exciting-breakthrough-offers-hope-for-long-covid-patients/
Opioid Addiction Medication Could Bring Relief to Long COVID Patients
Naltrexone offers hope for alleviating various long COVID symptoms, including brain fog and muscle fatigue.
Published: May 9, 2024 Blake Forman
Technology Networks, Immunology & Microbiology
I’ve lost everything: Globetrotting DJ bedbound by long Covid says condition cost him career, friends and mobility
Staff Reporter10 May 2024